GNA11 and hepatocellular carcinoma: Additionally, autoantibodies to PTCH1 and GNA11 are detected in 44.0% HCC sera, which are significantly higher than those in CH sera (18.5% to GNA11, 14.8% to GNA11) and NC sera (4.7%).